Twist Bioscience

Twist Bioscience Overview

Twist Bioscience Corporation's expertise is synthetic DNA. The company developed a proprietary, semiconductor-based synthetic-DNA manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools such as oligonucleotides, genes, pathways, chassis, and genomes. By synthesizing DNA on silicon instead of on traditional 96-well plastic plates, theplatform overcomes the current inefficiencies of synthetic DNA production and enables cost-effective, rapid, high-quality, and high-throughput synthetic gene production. Following the 2016 acquisition of Genome Compiler Corporation, a provider of software for genetic engineers and molecular and synthetic biologists, the company establisheda researchand development center in Tel Aviv. This acquisition soughtto leverage Genome Compiler's technology to drive a digital product portfolio, including an eCommerce solution with gene design capabilities. Theproducts will enable Twist Bioscience's customers to reimagine their research by providing seamless integration of the design and build of their synthetic DNA.

Latest News

Nov 1, 2018 · www.xconomy.com

N/A

Xconomy: Twist Bioscience IPO Hauls In $70M for DNA Synthesis Technology

The article does not provide any specific information about Informa PLC.

Jul 25, 2018 · officesnapshots.com

growth-positive

Office Tour: Twist Bioscience Offices - Tel Aviv

MOLET designed the office space for Twist Bioscience, a biotechnology company in Tel Aviv, Israel. The design incorporates the concept of DNA structure and properties, emphasizing connection and collaboration among employees. The office includes a meeting room, kitchen, workstations, and open spaces. The graphic design features elements related to DNAs physical structure. The project aims to support Twist Biosciences work in the fields of agriculture, medicine, industrial chemistry, and information storage. The article does not mention any specific partners, customers, valuation amount, acquisition amount, investment amount, layoffs, or date of the event.

CustomersPartners

Oct 21, 2016 · www.globes.co.il

growth-positive

US co Twist Bioscience buys Israel's Genome Compiler

Twist Bioscience has acquired Genome Compiler, an Israeli-based company providing software for genetic engineers. The financial details of the transaction were not disclosed. Twist Bioscience plans to leverage Genome Compilers technology and expertise to drive a digital products portfolio, including an eCommerce solution with gene design capabilities. The Genome Compiler research and development center in Israel will become Twist Biosciences first international site. Twist Bioscience intends to expand the center in Tel Aviv to advance its digital product and gene design capabilities. Genome Compiler was founded in 2011 and has raised $6 million to date from LionBirdVC, Autodesk, and private angel investors. Twist Bioscience raised $61 million in January 2016, making the total raised in two rounds $133 million.

AcquisitionPartners

Team Members

1

Employees: 11-50

Web & Social Links

Locations

Rothschild Street 3, Tel Aviv-Yafo, Israel

Photos & Videos

No files yet

Twist Bioscience Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info